Analyst Upgrades

• Auriga upgraded Computer Programs & Systems (CPSI) to hold from sell after channel checks indicated Q1 could be the bottom for stagnation of new system sales. The firm raised its target for shares to $38 from $32.
• Janney Montgomery upgraded Tetra Tech (TTEK) to buy from neutral due to valuation. The firm has a $26 price target on the stock.
• Deutsche Bank upgraded Energy Transfer Equity (ETE) to buy from hold and raised its target for shares to $40 from $27.
• Best Buy (BBY) was upgraded to buy from neutral at Goldman.
• Mariott (MAR) was raised to buy from sell at Societe Generale.
• Telus (TU) was upgraded at TD Newcrest to action list buy from buy.

Analyst Upgrades

• FBR Capital upgraded Nike (NKE) to outperform from market perform. The firm believes the company's momentum is building following the better-than-expected Q3 report and raised its target for the stock to $84 from $67.
• Thomas Weisel upgraded Corning (GLW) to overweight from market weight, citing improving profitability and cash flow trends. The firm has a $24 price target for shares.
• Deutsche Bank upgraded Burger King (BKC) to buy from hold, citing valuation and potential positive catalysts from the bottoming of sales trends and easy comparisons. The firm raised its price target on shares to $24 from $19.
• Broadcom (BRCM) was upgraded to buy from neutral at Goldman.
• Energizer (ENR) was upgraded to overweight from neutral at JPMorgan.
• Guess (GES) was upgraded to buy from hold at Lazard Capital.

Analyst Upgrades

• Credit Suisse upgraded Blackrock (BLK) to outperform from neutral and added shares to its U.S. Focus List. The firm cites valuation for the upgrade. The firm raised its target to $280 from $270.
• Keefe Bruyette upgraded Greenhill & Co. (GHL) to outperform from market perform following the company's acquisition of Caliburn. The firm raised its price target for shares to $110 from $82.
• Deutsche Bank upgraded Athenahealth (ATHN) to buy from hold, citing the removal of the company's accounting overhang and a strong long-term outlook. The firm raised its price target for shares to $51 from $40.
• Ann Taylor (ANN) was upgraded to neutral from underperform at BofA/Merrill.
• Jacobs Engineering (JEC) was upgraded to sell from conviction sell at Goldman.
• Sterling Bancorp (STL) was upgraded to outperform from market perform at BMO Capital.

Analyst Upgrades

• UBS upgraded Starbucks (SBUX) to buy from neutral, citing expectations for sales momentum. The firm raised its price target to $29 from $27.
• Piper Jaffray upgraded Sonic (SONC) two notches to overweight from underweight on expectations the company's sales and margin trends are set to improve. The firm raised its target price for shares to $12 from $8.
• BMO Capital upgraded Chicago Bridge & Iron (CBI) to outperform from market perform, citing its outlook for earnings growth. The firm has a $30 target on the stock.
• Clorox (CLX) was upgraded to overweight from equal weight at Barclays.
• Alexion Pharma (ALXN) was upgraded to conviction buy from buy at Goldman.
• Compellent (CML) was upgraded to buy from hold at ThinkEquity.

Starbucks (SBUX) is set to have a good morning, as the company received an upgrade from UBS to buy from neutral. The brokerage also upped its earnings forecast for Starbucks to $1.14 per share in fiscal 2010, up from $1.09 per share. For 2011, UBS expects Starbucks to pull in $1.34 per share, seven cents better than the brokerage's earlier forecast. UBS believes that benign costs and Starbucks' ongoing productivity programs are key to the company's success. That said, UBS feels that McDonald's (MCD) foray into the world of frappes and smoothies could "cannibalize frappuccino consumers from Starbucks." Such a move could hurt Starbucks' bottom line.

Yum! Brands (YUM), a collection of restaurant chains operating in the same space as McDonald's (MCD) and Burger King (BKC), didn't post the most exciting earnings report last month, but it might not matter. Just recently, shareholders received a couple pieces of good news.

First, UBS offered inspiring comments about the company and the stock last week. Shares were upgraded to buy status, rising from neutral. A higher price target of $44 was issued. The catalyst basically centers on things getting better on a fundamental basis for the restaurant brands; also, China's sales appear to have stabilized.

Analyst Upgrades

• FBR Capital upgraded Legg Mason (LM) to market perform from underperform, citing stabilizing outflows and an improved liquidity position.
• Walmart (WMT) was upgraded to buy from hold by Citigroup on expectations the company will regain market share from aggressive price cuts.
• Piper Jaffray upgraded Kirkland's (KIRK) to overweight from neutral following the company's Q4 results.
• Greenbrier (GBX) was upgraded to buy from hold by KeyBanc as the company believes that railcar fundamentals have improved.
• Citigroup upgraded WM Morrison (MRWSY) to buy from sell.
• HSBC raised Millicom (MICC) to overweight from neutral.
• HealthSouth (HLS) was raised to outperform from market perform by Raymond James.

Analyst Upgrades

• Deutsche Bank upgraded Southern Copper (SCCO) to buy from hold to reflect valuation and positive near-term catalysts. The firm raised its target for shares to $38 from $35.
• JMP Securities upgraded Ultimate Software (ULTI) to outperform from market perform. The firm cites the company's expanding employee base for the upgrade. The firm has a $40 target on the stock.
• Piper Jaffray upgraded Aeropostale (ARO) to neutral from underweight following the company's Q4 results and raised its target for shares to $31 from $24.
• Kennametal (KMT) was upgraded to sell from conviction sell at Goldman.
• Lifetime Brands (LCUT) was upgraded to outperform from market perform at Barrington.
• Volvo (VOLVY) was upgraded to overweight from underweight at JPMorgan.

Analyst Upgrades

• UBS upgraded Dr Pepper Snapple (DPS) to buy from neutral, citing strong fundamentals and buybacks. The firm raised its target to $42 from $31.
• Piper Jaffray upgraded ProAssurance (PRA) to overweight from neutral. The firm has a $76 price target on shares.
• Hershey (HSY) and Sunoco (SUN) were upgraded to sell from conviction sell at Goldman.
• Level 3 Comm (LVLT) was upgraded to neutral from underweight at JPMorgan.
• Cathay Pacific (CPCAY) was upgraded to buy from hold at Deutsche Bank.

Late Tuesday, an advisory panel of the Food & Drug Administration (FDA) voiced its approval for pirfenidone, the experimental lung drug from InterMune (ITMN). The panel voted 9-3 in favor of recommending pirfenidone to patients with idiopathic pulmonary fibrosis.

The FDA is expected to follow the advice of the advisory panel, although it's not required to do so. The regulatory agency is due to issue its final ruling on the drug's fate by early May.

Analyst Upgrades

• ThinkEquity upgraded InterMune (ITMN) to buy from hold following the FDA advisory committee's approval of Esbriet. InterMune was also upgraded to outperform from market perform at Wells Fargo.
• Piper Jaffray upgraded Radian (RDN) to neutral from underweight with a $9 target. The firm believes the company will not have to raise capital as the government is allowing it to increase its leverage ratio beyond historic maximum levels.
• JPMorgan upgraded ExlService (EXLS) to neutral from underweight following the company's Q4 results.
• Lockheed Martin (LMT) was upgraded to neutral from underperform at Macquarie.
• Analog Devices (ADI) was upgraded to outperform from market perform at Bernstein.
• Goodrich (GR) was upgraded to conviction buy from buy at Goldman.